<DOC>
	<DOCNO>NCT01917214</DOCNO>
	<brief_summary>This retrospective , non-interventional study look cohort Renal Cell Carcinoma patient real life clinical setting analysis factor patient survive long 3-5 year unlike Clinical study survival around 2 year . The factor analyse include patient characteristic , dosage adverse event management try correlate factor survival .</brief_summary>
	<brief_title>A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival</brief_title>
	<detailed_description>A single cohort 200 patient diagnose metastatic renal cell carcinoma prior 1st Jan 2012 , see medical oncologist center involve BIOGRID affiliate registry . Patients identify first date consultation medical oncologist capture electronic database . Consent use datasets already obtain participate research institute hospital IRB/Ethics Committees</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Age &gt; 18 Male female Metastatic renal cell cancer First presentation metastatic disease prior 1st Jan 2012 since 2006 , i.e . 1st Jan 2006 31st Dec 2011 No referral medical oncologist No record available electronic database</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>